Omitin 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 4.00 (100's pack: ৳ 400.00)
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Nipa pharmaceuticals ltd |
Also available as |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of the antisecretory effect within one hour
- Maximum effect within two hours
- Inhibition of secretion lasts up to 72 hours
- Gradual return of secretory activity over 3 to 5 days after discontinuation
Dosage
- Oral administration dosage recommendations
- Benign gastric and duodenal ulcer dosage
- NSAID-associated duodenal or gastric ulcer dosage
- Gastro-esophageal reflux disease dosage
- Long-term management of acid reflux disease dosage
- Acid-related dyspepsia dosage
- Prophylaxis of acid aspiration dosage
- Zollinger-Ellison syndrome dosage
- Helicobacter pylori eradication regimen in peptic ulcer disease dosage
- Pediatric use in severe ulcerating reflux esophagitis dosage
- IV Injection dosage recommendations
Administration
- Direction for use of IV Injection
- Direction for use of IV Infusion
- IV injection preparation and administration guidelines
- IV infusion preparation and administration guidelines
Interaction
- Impact on ketoconazole absorption
- Metabolism through cytochrome P450
- Potential delay in elimination of diazepam, phenytoin, and warfarin
- Monitoring recommendation for patients receiving warfarin or phenytoin
- Plasma concentrations of Omitin and clarithromycin during concomitant administration
- Absence of interaction with certain medications
Contraindications
- Known hypersensitivity
- Exclusion of malignancy before treatment
Side Effects
- Skin rash
- Urticaria
- Pruritus
- Photosensitivity
- Bullous eruption
- Diarrhoea
- Headache
- Constipation
- Nausea/vomiting
- Flatulence
- Abdominal pain
- Dry mouth
- Stomatitis
- Candidiasis
- Paraesthesia
- Dizziness
- Light headedness
- Feeling faint
- Somnolence
- Insomnia
- Vertigo
- Mental confusion
- Agitation
- Depression
- Hallucinations
- Arthritic symptoms
- Myalgic symptoms
- Blurred vision
- Taste disturbance
- Peripheral oedema
- Increased sweating
- Gynaecomastia
- Leucopenia
- Thrombocytopenia
- Agranulocytosis
- Pancytopenia
- Anaphylactic shock
- Malaise
- Fever
- Bronchospasm
- Encephalopathy in patients with severe liver disease
- Hepatitis with or without jaundice
- Interstitial nephritis
- Hepatic failure
- Increases in liver enzymes
Pregnancy & Lactation
- No adverse effects on pregnancy or fetus/newborn child
- Usability during pregnancy
- Impact on breast-feeding
Precautions & Warnings
- Avoid concomitant use of clopidogrel
- Risk for osteoporosis-related fractures
- Atrophic gastritis
- Concomitant use with methotrexate
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Omitin 40 mg (Capsule (Enteric Coated)) - nipa-pharmaceuticals-ltd
- Omizit 20 mg (Capsule (Enteric Coated)) - the-white-horse-pharmaceuticals-ltd
- Ompa 20 mg (Capsule (Enteric Coated)) - seema-pharmaceuticals-ltd
- Omrazol 20 mg (Capsule (Enteric Coated)) - ad-din-pharmaceuticals-ltd
- Omrazol 40 mg (Capsule (Enteric Coated)) - ad-din-pharmaceuticals-ltd